CM-4620 is primarily used in research and development within the pharmaceutical industry. It is studied for its potential therapeutic applications, particularly in targeting specific cellular pathways. Researchers are exploring its efficacy in treating conditions related to calcium signaling dysregulation, such as certain types of cancer and inflammatory diseases. Its role in modulating ion channels makes it a candidate for drug development aimed at addressing these health issues. Additionally, CM-4620 is utilized in preclinical studies to better understand its mechanism of action and to assess its safety and efficacy in various biological models.